A French multicenter retrospective cohort study with 41 patients with RP who were exposed to 105 biologics reported the efficacy of TCZ (n = 17) as well as TNFα inhibitors (n = 60) but a low number of complete responses and concerns about the risk of infection were reported [165]. This evidence concerns the gene TNF and infection.